Beam Therapeutics (BEAM) Short Interest Ratio & Short Volume → Does this make you sick? (From Allegiance Gold) (Ad) Free BEAM Stock Alerts $24.84 +0.22 (+0.89%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Beam Therapeutics Short Interest DataCurrent Short Interest14,020,000 sharesPrevious Short Interest13,170,000 sharesChange Vs. Previous Month+6.45%Dollar Volume Sold Short$297.50 millionShort Interest Ratio9.3 Days to CoverLast Record DateApril 30, 2024Outstanding Shares82,310,000 sharesPercentage of Shares Shorted17.03%Today's Trading Volume565,158 sharesAverage Trading Volume1,301,354 sharesToday's Volume Vs. Average43% Short Selling Beam Therapeutics ? Sign up to receive the latest short interest report for Beam Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBEAM Short Interest Over TimeBEAM Days to Cover Over TimeBEAM Percentage of Float Shorted Over Time Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Beam Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202414,020,000 shares $297.50 million +6.5%N/A9.3 $21.22 4/15/202413,170,000 shares $338.47 million -2.1%N/A8.4 $25.70 3/31/202413,450,000 shares $444.39 million -6.1%N/A9.7 $33.04 3/15/202414,320,000 shares $507.07 million +9.2%N/A10.1 $35.41 2/29/202413,110,000 shares $517.71 million -2.4%N/A9.2 $39.49 2/15/202413,430,000 shares $443.46 million +0.3%N/A9.6 $33.02 Get the Latest News and Ratings for BEAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202413,390,000 shares $326.72 million +2.0%N/A9.7 $24.40 1/15/202413,130,000 shares $336.13 million -2.7%N/A8.7 $25.60 12/31/202313,490,000 shares $367.20 million +0.1%N/A9.4 $27.22 12/15/202313,480,000 shares $383.10 million +3.7%N/A9.5 $28.42 11/30/202313,000,000 shares $365.04 million -6.0%N/A9.8 $28.08 11/15/202313,830,000 shares $347.82 million -4.3%N/A11.1 $25.15 10/31/202314,450,000 shares $305.47 million -4.3%N/A13.6 $21.14 10/15/202315,100,000 shares $336.13 million +5.2%N/A16.3 $22.26 9/30/202314,350,000 shares $345.12 million +6.2%N/A16.5 $24.05 9/15/202313,510,000 shares $338.43 million +2.9%N/A16.1 $25.05 8/31/202313,130,000 shares $304.35 million +0.5%N/A15.8 $23.18 8/15/202313,060,000 shares $316.97 million +8.8%N/A15.8 $24.27 7/31/202312,000,000 shares $370.44 million -3.7%N/A14.1 $30.87 7/15/202312,460,000 shares $384.52 million -1.4%N/A15.1 $30.86 6/30/202312,630,000 shares $403.28 million +1.5%N/A15.3 $31.93 6/15/202312,450,000 shares $423.30 million -0.5%N/A14.6 $34.00 5/31/202312,510,000 shares $399.07 million -4.9%20.0%13.6 $31.90 5/15/202313,150,000 shares $473.27 million +3.3%21.0%13.4 $35.99 4/30/202312,730,000 shares $390.94 million -1.1%21.4%13.7 $30.71 4/15/202312,870,000 shares $402.44 million -5.4%21.7%13.8 $31.27 3/31/202313,610,000 shares $416.74 million -2.2%22.9%14.6 $30.62 3/15/202313,910,000 shares $488.24 million +11.5%23.5%15.3 $35.10 2/28/202312,480,000 shares $502.20 million +4.4%21.1%14.9 $40.24 2/15/202311,950,000 shares $525.08 million -3.8%20.7%15.2 $43.94 1/31/202312,420,000 shares $539.65 million -4.5%21.5%14.8 $43.45 1/15/202313,010,000 shares $562.55 million +9.0%22.6%15.6 $43.24 12/30/202211,940,000 shares $466.97 million +1.7%20.7%14.3 $39.11 12/15/202211,740,000 shares $496.72 million -5.6%20.4%13.9 $42.31 11/30/202212,440,000 shares $574.60 million -4.4%21.6%14 $46.19 11/15/202213,010,000 shares $639.83 million -0.7%22.6%13.8 $49.18 10/31/202213,100,000 shares $577.19 million +0.2%23.8%12.2 $44.06 10/15/202213,080,000 shares $594.75 million -0.3%23.8%12.2 $45.47 9/30/202213,120,000 shares $625.04 million +5.8%23.9%11.3 $47.64 9/15/202212,400,000 shares $750.08 million +2.1%22.6%10 $60.49Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit 8/31/202212,140,000 shares $662.84 million +0.1%22.1%9.3 $54.60 8/15/202212,130,000 shares $852.86 million -6.5%22.1%9.2 $70.31 7/31/202212,970,000 shares $816.85 million -2.0%22.8%9.5 $62.98 7/15/202213,240,000 shares $762.89 million +3.4%23.3%9.5 $57.62 6/30/202212,810,000 shares $495.88 million +10.2%22.6%9.4 $38.71 6/15/202211,620,000 shares $371.26 million +4.6%20.5%8.7 $31.95 5/31/202211,110,000 shares $390.85 million -4.9%19.7%9.1 $35.18 5/15/202211,680,000 shares $414.06 million +8.1%21.7%9.9 $35.45 4/30/202210,810,000 shares $405.70 million +10.5%20.1%10.3 $37.53 4/15/20229,780,000 shares $453.79 million +10.9%18.5%9.3 $46.40 3/31/20228,820,000 shares $505.39 million +3.6%16.9%8.4 $57.30 3/15/20228,510,000 shares $470.09 million -3.6%16.3%9.1 $55.24 2/28/20228,830,000 shares $691.83 million +7.6%17.1%9.8 $78.35 2/15/20228,210,000 shares $606.47 million +4.7%15.9%9.5 $73.87 1/31/20227,840,000 shares $542.61 million +26.5%15.2%9.7 $69.21 1/15/20226,200,000 shares $420.48 million +11.3%11.5%8.8 $67.82 12/31/20215,570,000 shares $443.87 million +1.1%10.4%9.5 $79.69 12/15/20215,510,000 shares $443.72 million +5.6%10.2%9.3 $80.53 11/30/20215,220,000 shares $413.16 million +7.6%9.8%8.6 $79.15 11/15/20214,850,000 shares $419.23 million +3.9%9.1%8.1 $86.44 10/29/20214,670,000 shares $414.56 million -15.4%9.4%7.7 $88.77 10/15/20215,520,000 shares $514.13 million +9.5%11.2%8.7 $93.14 9/30/20215,040,000 shares $438.53 million -3.5%10.2%7.6 $87.01 9/15/20215,220,000 shares $533.01 million -5.6%10.6%6.3 $102.11 8/31/20215,530,000 shares $613.39 million +7.2%11.4%7 $110.92 8/13/20215,160,000 shares $521.26 million +2.8%10.8%6.5 $101.02 7/30/20215,020,000 shares $461.84 million +3.3%11.3%5.8 $92.00 7/15/20214,860,000 shares $415.77 million -9.0%10.9%5.6 $85.55 6/30/20215,340,000 shares $687.31 million -17.5%12.0%5.8 $128.71 6/15/20216,470,000 shares $572.34 million -2.1%15.0%8.1 $88.46 5/28/20216,610,000 shares $517.10 million -4.1%15.3%7.8 $78.23 5/14/20216,890,000 shares $455.70 million +4.7%15.1%6.8 $66.14 4/30/20216,580,000 shares $513.90 million -5.9%14.5%6.3 $78.10 4/15/20216,990,000 shares $534.39 million +3.0%17.6%6.5 $76.45 3/31/20216,790,000 shares $514.41 million +0.3%18.1%6.1 $75.76 3/15/20216,770,000 shares $666.30 million +17.1%18.9%5.9 $98.42 2/26/20215,780,000 shares $511.65 million +8.2%17.7%5 $88.52 2/12/20215,340,000 shares $558.88 million -4.3%16.4%5.2 $104.66 1/29/20215,580,000 shares $557.39 million +0.9%17.1%5.9 $99.89 1/15/20215,530,000 shares $615.60 million No Change16.8%6.1 $111.32 BEAM Short Interest - Frequently Asked Questions What is Beam Therapeutics' current short interest? Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 14,020,000 shares of BEAM short. Learn More on Beam Therapeutics' current short interest. What is a good short interest ratio for Beam Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 9.0. Learn More on Beam Therapeutics's short interest ratio. Which institutional investors are shorting Beam Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Beam Therapeutics: Walleye Trading LLC, Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Beam Therapeutics' short interest increasing or decreasing? Beam Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 14,020,000 shares, an increase of 6.5% from the previous total of 13,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Beam Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Beam Therapeutics: Sana Biotechnology, Inc. (20.85%), Novavax, Inc. (32.00%), ADMA Biologics, Inc. (3.82%), Ginkgo Bioworks Holdings, Inc. (20.84%), Fusion Pharmaceuticals Inc. (4.64%), Kymera Therapeutics, Inc. (16.15%), Inhibrx, Inc. (4.18%), Apogee Therapeutics, Inc. (14.00%), Recursion Pharmaceuticals, Inc. (24.98%), Vericel Co. (9.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Beam Therapeutics stock? Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Beam Therapeutics? A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further. How often is Beam Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SANA Short Interest Data NVAX Short Interest Data ADMA Short Interest Data DNA Short Interest Data FUSN Short Interest Data KYMR Short Interest Data INBX Short Interest Data APGE Short Interest Data RXRX Short Interest Data VCEL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAM) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss Ratings